» Articles » PMID: 17071926

The Neuropathology of Frontotemporal Lobar Degeneration Caused by Mutations in the Progranulin Gene

Overview
Journal Brain
Specialty Neurology
Date 2006 Oct 31
PMID 17071926
Citations 123
Authors
Affiliations
Soon will be listed here.
Abstract

The most common pathology in frontotemporal dementia (FTD) is tau-negative, ubiquitin-immunoreactive (ub-ir) neuronal inclusions (FTLD-U). Recently, we identified mutations in the progranulin (PGRN) gene as the cause of autosomal dominant FTLD-U linked to chromosome 17. Here, we describe the neuropathology in 13 patients from 6 different families, each with FTD caused by a different PGRN mutation. The most consistent feature was the presence of ub-ir lentiform neuronal intranuclear inclusions (NII) in the neocortex and striatum. In addition, the neocortex showed moderate-to-severe superficial laminar spongiosis, chronic degenerative changes, ub-ir neurites and well-defined ub-ir neuronal cytoplasmic inclusions (NCI). In the striatum, there were numerous ub-ir neurites. NCI in the hippocampus usually had a granular appearance. In contrast, familial FTLD-U cases without PGRN mutations had no NII, less severe neocortical and striatal pathology and hippocampal NCI that were more often solid. Eight cases in which genetic analysis was not available also had NII and an overall pathology similar to those with proven mutations. None of our cases of FTLD-U without NII showed the same pattern of pathology as those with mutations. These findings suggest that FTD caused by PGRN mutations has a recognizable pathology with the most characteristic feature being ub-ir NII.

Citing Articles

Large-scale CSF proteome profiling identifies biomarkers for accurate diagnosis of Frontotemporal Dementia.

Hok-A-Hin Y, Vermunt L, Peeters C, van der Ende E, de Boer S, Meeter L medRxiv. 2024; .

PMID: 39228745 PMC: 11370532. DOI: 10.1101/2024.08.19.24312100.


Benzoxazole-derivatives enhance progranulin expression and reverse the aberrant lysosomal proteome caused by GRN haploinsufficiency.

Tesla R, Guhl C, Werthmann G, Dixon D, Cenik B, Addepalli Y Nat Commun. 2024; 15(1):6125.

PMID: 39033178 PMC: 11271458. DOI: 10.1038/s41467-024-50076-8.


Evaluating the Effect of Alzheimer's Disease-Related Biomarker Change in Corticobasal Syndrome and Progressive Supranuclear Palsy.

Garcia-Cordero I, Anastassiadis C, Khoja A, Morales-Rivero A, Thapa S, Vasilevskaya A Ann Neurol. 2024; 96(1):99-109.

PMID: 38578117 PMC: 11249787. DOI: 10.1002/ana.26930.


TMEM106B core deposition associates with TDP-43 pathology and is increased in risk SNP carriers for frontotemporal dementia.

Marks J, Estades Ayuso V, Carlomagno Y, Yue M, Todd T, Hao Y Sci Transl Med. 2024; 16(730):eadf9735.

PMID: 38232138 PMC: 10841341. DOI: 10.1126/scitranslmed.adf9735.


A case of familial frontotemporal dementia caused by a progranulin gene mutation.

Currens L, Harrison N, Schmidt M, Amjad H, Mu W, Scholz S Clin Park Relat Disord. 2023; 9:100213.

PMID: 37583427 PMC: 10424124. DOI: 10.1016/j.prdoa.2023.100213.